Drug induced hepatotoxicity in targeted therapy for lung cancer
作者： Shaoyu Yang , Xueqin Chen , Shenglin Ma
DOI: 10.3779/J.ISSN.1009-3419.2014.09.08
关键词:
摘要: Targeted drugs aimed at driver gene, such as Gefitinib, Erlotinib and Crizotinib, have an irreplaceable position in the therapy of advanced non-small cell lung cancer. These bring benefit to patients, however, higher hepatotoxicity is also presented. Now, drug induced its mechanism are reviewed.
sci-hub.st 参考文章(29)
Yoshiro Fujiwara, Katsuyuki Kiura, Shinichi Toyooka, Nagio Takigawa, Masaki Tokumo, Katsuyuki Hotta, Motoi Aoe, Masahiro Tabata, Keitaro Matsuo, Hiroshi Date, Mitsune Tanimoto, Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancer Lung Cancer. ,vol. 52, pp. 99- 103 ,(2006) , 10.1016/J.LUNGCAN.2005.12.004
Ying Li, Yongwen Li, Tong Yang, Sen Wei, Jing Wang, Min Wang, Yuli Wang, Qinghua Zhou, Hongyu Liu, Jun Chen, Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer PLoS ONE. ,vol. 8, pp. e52093- ,(2013) , 10.1371/JOURNAL.PONE.0052093
Nobuhiko Seki, Kazutsugu Uematsu, Reishi Shibakuki, Kenji Eguchi, Promising New Treatment Schedule for Gefitinib Responders After Severe Hepatotoxicity With Daily Administration Journal of Clinical Oncology. ,vol. 24, pp. 3213- 3214 ,(2006) , 10.1200/JCO.2006.05.7109
Takayuki Takimoto, Takashi Kijima, Yasushi Otani, Shinpei Nonen, Yoshinobu Namba, Masahide Mori, Soichiro Yokota, Seigo Minami, Kiyoshi Komuta, Junji Uchida, Fumio Imamura, Mitsugi Furukawa, Naotoshi Tsuruta, Yasushi Fujio, Junichi Azuma, Isao Tachibana, Atsushi Kumanogoh, Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity. Clinical Lung Cancer. ,vol. 14, pp. 502- 507 ,(2013) , 10.1016/J.CLLC.2013.03.003
Yi Ling Teo, Han Kiat Ho, Alexandre Chan, Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis Cancer Treatment Reviews. ,vol. 39, pp. 199- 206 ,(2013) , 10.1016/J.CTRV.2012.09.004
Xueqin Chen, Yuelong Pan, Shirong Zhang, Dadong Chen, Shaoyu Yang, Xin Li, Shenglin Ma, None, Rechallenge with gefitinib following severe drug-induced hepatotoxicity in a patient with advanced non-small cell lung cancer: A case report and literature review. Oncology Letters. ,vol. 7, pp. 878- 880 ,(2014) , 10.3892/OL.2013.1756
Alice T. Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J. Solomon, Fiona Blackhall, Yi-Long Wu, Michael Thomas, Kenneth J. O'Byrne, Denis Moro-Sibilot, D. Ross Camidge, Tony Mok, Vera Hirsh, Gregory J. Riely, Shrividya Iyer, Vanessa Tassell, Anna Polli, Keith D. Wilner, Pasi A. Jänne, Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer The New England Journal of Medicine. ,vol. 368, pp. 2385- 2394 ,(2013) , 10.1056/NEJMOA1214886
Tao Xue, Peihua Luo, Hong Zhu, Yuqin Zhao, Honghai Wu, Renhua Gai, Youping Wu, Bo Yang, Xiaochun Yang, Qiaojun He, Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes Toxicology and Applied Pharmacology. ,vol. 261, pp. 280- 291 ,(2012) , 10.1016/J.TAAP.2012.04.010
SEVKET OZKAYA, SERHAT FINDIK, ADEM DIRICAN, ATILLA GÜVEN ATICI, Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine Experimental and Therapeutic Medicine. ,vol. 4, pp. 1035- 1038 ,(2012) , 10.3892/ETM.2012.714
Geoffrey Y. Ku, Akhil Chopra, Gilberto de Lima Lopes, Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity Lung Cancer. ,vol. 70, pp. 223- 225 ,(2010) , 10.1016/J.LUNGCAN.2010.08.012